Robert M. Hohlman

ChemistryMedicineBiochemistry, Genetics and Molecular BiologyPharmacology, Toxicology and PharmaceuticsMaterials Science

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Development of substituted benzimidazoles as inhibitors of human aldehyde dehydrogenase 1A isoenzymes”.

Development of substituted benzimidazoles as inhibitors of human aldehyde dehydrogenase 1A isoenzymes

Chemico-Biological Interactions(2024)10.1016/j.cbi.2024.110910

N/A

0.241DataRank · unranked

4 citations

Mikhail Chtcherbinine, Brandt C. Huddle, Michael W. Wilson, Timothy Emmel, Robert M. Hohlman +5 more

Multicomponent Microscale Biosynthesis of Unnatural Cyanobacterial Indole Alkaloids

ACS Synthetic Biology(2020)10.1021/acssynbio.0c00038

N/A

0DataRank · unranked

26 citations

Robert M. Hohlman, Johnny Mendoza, Shasha Li, Andrew N. Lowell, Haruichi Asahara +2 more

Recent advances in hapalindole-type cyanobacterial alkaloids: biosynthesis, synthesis, and biological activity

Natural Product Reports(2021)10.1039/d1np00007a

N/A

0DataRank · unranked

53 citations

David H. Sherman, Robert M. Hohlman